[Anal incontinence--assessment of a new treatment].
BACKGROUND
Anal incontinence affects 1.4 % of the general population. Anal injections is a new treatment option for this condition; different techniques and bulking agents are used. The article presents a pilot-study with a new bulking agent (hyaluronic acid and dextranomere) and a new injection technique.


METHODS
An anascope was used to inject Zuidex (4 x 1. 4 mL) submucosally (proximal to the dentate line and distally to the puborectal muscle) in 4 patients with severe faecal incontinence, who were deemed unfit for other treatment. No anaesthesia or antibiotic-prophylaxis was used.


RESULTS
All patients tolerated the treatment well, and there were no adverse events. The treatment had an effect in 3 of 4 patients; there was a median fall in St. Mark's score of 3. 5 points.


CONCLUSIONS
The injection technique was well tolerated, easy to perform within an outpatient setting and with promising short-term results. The method has been implemented in a randomized, controlled trial.
Dehli
Trond
T
Avdeling for gastroenterologisk kirurgi, Universitetssykehuset Nord-Norge, 9016 Tromsø. trond.dehli@unn.no
Lindsetmo
Rolv-Ole
RO
Mevik
Kjersti
K
Vonen
Barthold
B
D000368:Aged; D001003:Anal Canal; D003911:Dextrans / Q000008:administration & dosage*; D005242:Fecal Incontinence / Q000188:drug therapy*; D005260:Female; D005782:Gels; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage*; D007267:Injections; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D003911:Dextrans; D005782:Gels; D006820:Hyaluronic Acid